Abstract
Dimethylbenzanthracene (DMBA), a strong tumor initiator, did not show mutagenic activity in the soybean test system either alone or in combination with tumor promoter, TPA. In combination treatments with DMBA and gamma-rays, the mutagenicity of gamma-rays was not affected by post-treatment with DMBA. However, DMBA pre-treatment clearly reduced gammaray-ray induced spotting frequency, suggesting that DMBA affects mutagenesis in gamma-irradiated soybean cells.
